These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 27544586)

  • 21. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses.
    Zhu W; Smith G; Pickering B; Banadyga L; Yang M
    Viruses; 2024 May; 16(5):. PubMed ID: 38793674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models.
    Lawrence P; Escudero-Pérez B
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.
    Mungall BA; Middleton D; Crameri G; Bingham J; Halpin K; Russell G; Green D; McEachern J; Pritchard LI; Eaton BT; Wang LF; Bossart KN; Broder CC
    J Virol; 2006 Dec; 80(24):12293-302. PubMed ID: 17005664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of exposure to henipaviruses in domestic pigs in Uganda.
    Atherstone C; Diederich S; Weingartl HM; Fischer K; Balkema-Buschmann A; Grace D; Alonso S; Dhand NK; Ward MP; Mor SM
    Transbound Emerg Dis; 2019 Mar; 66(2):921-928. PubMed ID: 30576076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.
    Yin C; Yao YF; Yang P; Liu H; Gao G; Peng Y; Chen M; Lu M; Zhang X; Guo W; Zhang Z; Hu X; Yuan Z; Shan C
    Front Immunol; 2024; 15():1387811. PubMed ID: 38911870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses in mice and pigs after oral vaccination with rabies virus vectored Nipah disease vaccines.
    Shuai L; Ge J; Wen Z; Wang J; Wang X; Bu Z
    Vet Microbiol; 2020 Feb; 241():108549. PubMed ID: 31928698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
    Monath TP; Nichols R; Feldmann F; Griffin A; Haddock E; Callison J; Meade-White K; Okumura A; Lovaglio J; Hanley PW; Clancy CS; Shaia C; Rida W; Fusco J
    Front Immunol; 2023; 14():1216225. PubMed ID: 37731485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins.
    Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D
    Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.
    Dong J; Cross RW; Doyle MP; Kose N; Mousa JJ; Annand EJ; Borisevich V; Agans KN; Sutton R; Nargi R; Majedi M; Fenton KA; Reichard W; Bombardi RG; Geisbert TW; Crowe JE
    Cell; 2020 Dec; 183(6):1536-1550.e17. PubMed ID: 33306954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs.
    Kong D; Wen Z; Su H; Ge J; Chen W; Wang X; Wu C; Yang C; Chen H; Bu Z
    Virology; 2012 Oct; 432(2):327-35. PubMed ID: 22726244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A treatment for and vaccine against the deadly Hendra and Nipah viruses.
    Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF
    Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Henipavirus: a review of laboratory animal pathology.
    Williamson MM; Torres-Velez FJ
    Vet Pathol; 2010 Sep; 47(5):871-80. PubMed ID: 20682803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Henipaviruses: an expanding global public health concern?
    Quarleri J; Galvan V; Delpino MV
    Geroscience; 2022 Oct; 44(5):2447-2459. PubMed ID: 36219280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol.
    Lara A; Cong Y; Jahrling PB; Mednikov M; Postnikova E; Yu S; Munster V; Holbrook MR
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007454. PubMed ID: 31166946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial infections in pigs experimentally infected with Nipah virus.
    Berhane Y; Weingartl HM; Lopez J; Neufeld J; Czub S; Embury-Hyatt C; Goolia M; Copps J; Czub M
    Transbound Emerg Dis; 2008 May; 55(3-4):165-74. PubMed ID: 18405339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
    Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
    Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
    Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
    PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
    Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
    Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
    Amaya M; Yin R; Yan L; Borisevich V; Adhikari BN; Bennett A; Malagon F; Cer RZ; Bishop-Lilly KA; Dimitrov AS; Cross RW; Geisbert TW; Broder CC
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.
    Mire CE; Geisbert JB; Agans KN; Versteeg KM; Deer DJ; Satterfield BA; Fenton KA; Geisbert TW
    Emerg Infect Dis; 2019 Jun; 25(6):1144-1152. PubMed ID: 31107231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.